News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
193 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (21)
2 (28)
3 (291)
4 (299)
5 (210)
6 (198)
7 (88)
8 (20)
9 (26)
10 (204)
11 (264)
12 (223)
13 (206)
14 (127)
15 (5)
16 (12)
17 (183)
18 (268)
19 (197)
20 (202)
21 (95)
22 (5)
23 (6)
24 (193)
25 (218)
26 (195)
27 (217)
28 (97)
29 (2)
30 (3)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
The Medicines Company Announces Launch of Public Offering of Common Stock
The Company expects to use the net proceeds of the offering to fund its development of inclisiran and for general corporate purposes.
June 24, 2019
·
3 min read
Pharm Country
Rinovum Women’s Health Debuts Revolutionary Reusable Over-the-Counter Product Clinically Proven To Treat Light Bladder Leaks and Boost Women’s Confidence
Rinovum Women’s Health, the makers of the successful Stork® products for at-home conception has debuted a breakthrough reusable device, clinically proven to treat light bladder leaks that does not require a prescription, impacting the more than 15 million women in the U.S. who suffer from the embarrassing issue.
June 24, 2019
·
3 min read
Pharm Country
The American Journal of Managed Care® Launches ‘An Introduction of a New Class for the Treatment of Bone Health’
The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presents its most recent “Peer Exchange” panel discussion, “An Introduction of a New Class for the Treatment of Bone Health.”
June 24, 2019
·
3 min read
Deals
Centene and WellCare Stockholders Approve Proposals Regarding Centene’s Pending Acquisition of WellCare
Centene Corporation (NYSE: CNC) (“Centene”) and WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) today announced that the stockholders of both companies approved all proposals regarding Centene’s pending acquisition of WellCare pursuant to the definitive merger agreement between the parties.
June 24, 2019
·
21 min read
Business
Maricopa Integrated Health System and nThrive to Present at the 2019 HFMA Annual Conference
Thought leaders from Arizona-based Maricopa Integrated Health System and nThrive will share how a holistic approach to denials management can help providers thrive in the new clinically-driven revenue cycle management environment
June 24, 2019
·
2 min read
Pharm Country
Newly Published Article Reporting Clinical Activity of Orally Administered OKT3, a Mouse Anti-CD3 Monoclonal Antibody, in Moderate to Severe Ulcerative Colitis Patients, Supports Tiziana’s Oral Monoclonal Antibody Platform
Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, notes the advance publication of a scientific article by third party researchers in the peer reviewed journal Crohn’s & Colitis 360
June 24, 2019
·
5 min read
Bio NC
ECU Research Shows Fewer Males Born in U.S. During Periods of Stress
It is a common understanding in scientific research that the male species, in general, are frailer and experience higher rates of mortality across their lifespans than females.
June 24, 2019
·
3 min read
Drug Development
Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)
These top-line results demonstrate HD201’s exceptional similarity to Herceptin in terms of clinical response and PK
June 24, 2019
·
2 min read
Business
Sensyne Health, Evotec, OSI and the University of Oxford create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at the University of Oxford
June 24, 2019
·
10 min read
Biotech Bay
LeanMD Looks to End the Obesity Epidemic One Person at a Time
Obesity is One of the Largest Drivers of Preventable Chronic Disease; LeanMD’s 360 Degree Solution is Medically Supervised, Pharmaceutically Enhanced, and Features Advancements in Healthcare
June 24, 2019
·
3 min read
Previous
17 of 20
Next